First-Line Treatments for Metastatic Clear Cell Renal Cell Carcinoma: An Ever-Enlarging Landscape.

Gulati, Shuchi; Labaki, Chris; Karachaliou, Georgia Sofia; Choueiri, Toni K; Zhang, Tian

Gulati, Shuchi; Labaki, Chris; Karachaliou, Georgia Sofia; Choueiri, Toni K; Zhang, Tian.

Afiliação

Gulati S; Division of Hematology and Oncology, Department of Medicine, University of Cincinnati, Cincinnati, OH, USA.
Labaki C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Karachaliou GS; Division of Medical Oncology, Department of Medicine, Duke University, Durham, NC, USA.
Choueiri TK; Duke Cancer Institute Center for Prostate and Urologic Cancers, Durham, NC, USA.
Zhang T; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.

Oncologist ; 27(2): 125-134, 2022 03 04.

Article em En | MEDLINE | ID: mdl-35641205

Assuntos

Carcinoma de Células Renais; Neoplasias Renais; Axitinibe/uso terapêutico; Carcinoma de Células Renais/patologia; Humanos; Neoplasias Renais/patologia; Nivolumabe/uso terapêutico

Palavras-chave

immunotherapy; metastatic RCC; new therapeutic targets; renal cell carcinoma

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Oncologist Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google